brand semaglutide FDA warns about safety of 'off-brand' versions of Ozempic, Wegovy US FDA approves weight loss

#HEOR #MarketAccess #GLP1 #Tirzepatide #Semaglutide #ObesityCare #SleepHealth #RealWorldEvidence Read the full study: New evidence from a study lead by Prof Onur Baser supports the role of GLP-1 therapies in managing obesity-related obstructive sleep apnea (OSA)

Nearly 12% of Americans have used GLP-1 drugssuch as Ozempicfor weight loss

Side Effects: While rare, side effects from the lipotropic components can occur, including gastrointestinal discomfort, fatigue, and allergic reactions

It is found in saliva, urine, and various tissues and its concentrations in plasma decline with age

Over time these toxins can build up and affect energy, immunity, and metabolic health

As an advocate for meaningful change in how obesity is understood, Sophie works to reduce stigma and raise awareness of the condition as an illness